Authors: Jacqueline R. Kulbe; Sonia Jain; Lindsay D. Nelson; Frederick K. Korley; Pratik Mukherjee; Xiaoying Sun; David O. Okonkwo; Joseph T. Giacino; Mary J. Vassar; Claudia S. Robertson; Michael A. McCrea; Kevin K. W. Wang; Nancy Temkin; Christine L. Mac Donald; Sabrina R. Taylor; Adam R. Ferguson; Amy J. Markowitz; Ramon Diaz-Arrastia; Geoffrey T. Manley; Murray B. Stein · Research
Can Blood Tests Help Predict PTSD Risk After Mild Brain Injury?
Research reveals surprising link between blood biomarkers and PTSD development after mild traumatic brain injury
Source: Kulbe, J. R., Jain, S., Nelson, L. D., Korley, F. K., Mukherjee, P., Sun, X., ... & Stein, M. B. (2022). Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury. Neuropsychopharmacology, 47(13), 2300-2308.
What you need to know
- A blood test measuring GFAP (a brain injury marker) taken within 24 hours of a mild brain injury may help predict who is at risk for developing PTSD
- Surprisingly, higher levels of GFAP were associated with lower risk of developing PTSD 6 months after injury
- About 20% of patients with mild traumatic brain injury developed PTSD within 6 months
The Connection Between Brain Injury and PTSD
Imagine getting into a car accident and hitting your head. In the emergency room, doctors tell you that you have a mild traumatic brain injury (mTBI), also known as a concussion. While many people recover fully from mTBIs, some go on to develop mental health challenges like post-traumatic stress disorder (PTSD). But who is most likely to develop PTSD after a brain injury? New research suggests that a simple blood test might help answer this question.
What is GFAP and Why Does it Matter?
GFAP (glial fibrillary acidic protein) is a substance released by brain cells called astrocytes when they’re damaged. Think of GFAP as a distress signal that your brain sends out after injury - the more damage there is, the stronger the signal. Doctors can measure GFAP levels in the blood within 24 hours of injury to help determine how severe a brain injury might be.
The Surprising Finding
The researchers studied over 1,100 patients who had experienced mild traumatic brain injuries. They found that about 20% developed PTSD within 6 months of their injury. But here’s the surprising part: patients with higher GFAP levels in their blood right after injury were actually less likely to develop PTSD later on.
This finding was unexpected because the researchers originally thought that more severe brain injury (indicated by higher GFAP) would lead to a higher risk of PTSD. Instead, they found the opposite.
Why Might This Happen?
The researchers suggest that higher levels of GFAP might indicate injury to parts of the brain involved in forming and storing memories of the traumatic event. If someone can’t fully remember the traumatic experience, they might be less likely to develop PTSD. It’s similar to how some people who lose consciousness during a traumatic event are less likely to develop PTSD compared to those who remain conscious throughout.
What This Means for You
If you or someone you know experiences a mild traumatic brain injury:
- Know that while most people recover well, about 20% may develop PTSD
- A GFAP blood test within 24 hours of injury might help predict PTSD risk
- Lower GFAP levels don’t mean you’re “fine” - you might actually need more careful monitoring for PTSD
- Early identification of risk could help get proper mental health support sooner
- Remember that other factors, like previous mental health history and type of injury, also affect PTSD risk
Conclusions
- Blood tests measuring GFAP could become part of standard care after brain injury to help identify who might need closer mental health monitoring
- The relationship between brain injury severity and PTSD risk is more complex than previously thought
- More research is needed to understand exactly how brain injury affects PTSD development and to develop better prediction tools